共 39 条
- [21] Evaluation of single maintenance and reliever therapy (SMART) prescribing of budesonide-formoterol for asthma after a clinical pharmacist-led initiative JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2024, 7 (03): : 215 - 223
- [22] Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark - Cost-effectiveness analysis based on five randomised controlled trials CLINICAL RESPIRATORY JOURNAL, 2009, 3 (03): : 169 - 180
- [23] Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial LANCET RESPIRATORY MEDICINE, 2013, 1 (01): : 32 - 42
- [25] Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5441 - 5450
- [26] Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance Therapy JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (07): : 2104 - 2114.e3